DLPIC
ABBV icon

Davide Leone & Partners Investment Company’s AbbVie ABBV Stock Holding History

Davide Leone & Partners Investment Company’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,400,000
Closed -$82M – 14
2015
Q1 		$82M Sell
1,400,000
-150,000
-10% -$9.06M 6.7% 9
2014
Q4 		$101M Buy
1,550,000
+650,000
+72% +$41M 8.32% 4
2014
Q3 		$52M Buy
+900,000
New +$50M 5.98% 9

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Davide Leone & Partners Investment Company's ABBV Position: Q3 2014 in Review

Davide Leone & Partners Investment Company sold out of AbbVie (ABBV) in Q3 2014, closing a stake of 150,000 shares — an estimated $8.33M sold.

Davide Leone & Partners Investment Company first reported a position in ABBV in Q2 2014 and held it in 1 quarter. The position peaked at $8.47M in Q2 2014. 1,502 funds tracked by Wall St. Rank hold ABBV as of Q3 2014.

  • Davide Leone & Partners Investment Company reported no remaining AbbVie position as of Q3 2014 after selling out during the quarter.
  • Davide Leone & Partners Investment Company sold 150,000 AbbVie shares in Q3 2014, an estimated $8.33M.
  • Davide Leone & Partners Investment Company first reported a position in AbbVie in Q2 2014 and held it in 1 quarter.
  • Davide Leone & Partners Investment Company's AbbVie position peaked at $8.47M in Q2 2014.
  • 1,502 funds tracked by Wall St. Rank held AbbVie as of Q3 2014.

Based on Davide Leone & Partners Investment Company's 13F filing for Q3 2014, filed 14 Nov 2014.